Anthropic shares early progress using Claude for drug discovery

Anthropic has announced progress deploying Claude, its AI model, to accelerate drug development and disease research. The company has formed partnerships with six organizations focused on curing disease and has begun its own drug discovery initiatives, including work on rare childhood forms of muscular dystrophy.

The announcement suggests that large language models are being tested in pharmaceutical research and development workflows, potentially to speed up the discovery and development process.